Praxis Precision Medicines
PRAX
PRAX
149 hedge funds and large institutions have $886M invested in Praxis Precision Medicines in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 51 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less call options, than puts
Call options by funds: $17.8M | Put options by funds: $22.8M
26% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 46
47% less capital invested
Capital invested by funds: $1.67B → $886M (-$786M)
Holders
149
Holding in Top 10
7
Calls
$17.8M
Puts
$22.8M
Top Buyers
| 1 | +$43.1M | |
| 2 | +$33.9M | |
| 3 | +$23.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$22.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$17.2M |
Top Sellers
| 1 | -$58.6M | |
| 2 | -$23.3M | |
| 3 | -$13.2M | |
| 4 |
SC
Stempoint Capital
New York
|
-$10.3M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$10M |
